{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:35:04Z","timestamp":1793054104095,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neuroscience.2026.07.057","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:42:30Z","timestamp":1785166950000},"page":"297-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pharmacological potential of wogonin in rotenone induced mice model of Parkinson\u2019s disease via targeting GSK-3\u03b2"],"prefix":"10.1016","volume":"612","author":[{"given":"Kajal","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Chib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randhir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neuroscience.2026.07.057_b0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5694\/mja2.50224","article-title":"Updates and advances in the treatment of Parkinson disease","volume":"211","author":"Hayes","year":"2019","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.neuroscience.2026.07.057_b0010","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/jnc.13691","article-title":"The clinical symptoms of Parkinson's disease","volume":"139","author":"Sveinbjornsdottir","year":"2016","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.07.057_b0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03159935","article-title":"Pathology of Parkinson\u2019s disease: changes other than the nigrostriatal pathway","volume":"14","author":"Jellinger","year":"1991","journal-title":"Mol. Chem. Neuropathol."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.07.057_b0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00702-017-1692-0","article-title":"Parkinson\u2019s disease as a multisystem disorder","volume":"124","author":"Klingelhoefer","year":"2017","journal-title":"J. Neural Transm."},{"issue":"11","key":"10.1016\/j.neuroscience.2026.07.057_b0025","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.neurol.2015.07.011","article-title":"Animal models of Parkinson's disease: an updated overview","volume":"171","author":"Gubellini","year":"2015","journal-title":"Rev. Neurol."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.07.057_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13205-025-04267-9","article-title":"Targeting dopaminergic neuronal death: luteolin as a therapeutic modulator in Parkinson\u2019s disease","volume":"15","author":"Chib","year":"2025","journal-title":"3 Biotech"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.07.057_b0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.expneurol.2010.03.028","article-title":"Complex I: inhibitors, inhibition and neurodegeneration","volume":"224","author":"Schapira","year":"2010","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.07.057_b0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.toxlet.2014.11.029","article-title":"The molecular mechanism of rotenone-induced \u03b1-synuclein aggregation: emphasizing the role of the calcium\/GSK3\u03b2 pathway","volume":"233","author":"Yuan","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuroscience.2026.07.057_b0045","first-page":"1","article-title":"\u03b2-Caryophyllene (CB2 agonist) mitigates rotenone-induced neurotoxicity and apoptosis in SH-SY5Y neuroblastoma cells via modulation of GSK-3\u03b2\/NRF2\/HO-1 axis","author":"Rathod","year":"2025","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacol."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.07.057_b0055","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.3390\/biomedicines10092116","article-title":"Inflammatory cytokine: an attractive target for cancer treatment","volume":"10","author":"Lee","year":"2022","journal-title":"Biomedicines"},{"issue":"94","key":"10.1016\/j.neuroscience.2026.07.057_b0060","article-title":"Manganese and related neurotoxic pathways: a potential therapeutic target in neurodegenerative diseases","volume":"1","author":"Chib","year":"2022","journal-title":"Neurotoxicol. Teratol."},{"issue":"15","key":"10.1016\/j.neuroscience.2026.07.057_b0065","article-title":"A comparative study of the quality differences and seasonal dynamics of flavonoids between the aerial parts and roots of Scutellaria barbata","volume":"2","author":"Cheng","year":"2024","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.neuroscience.2026.07.057_b0070","first-page":"2935","article-title":"Advances of wogonin, an extract from Scutellaria baicalensis, for the treatment of multiple tumors","volume":"17","author":"Wu","year":"2016","journal-title":"OncoTargets and Therapy"},{"issue":"12","key":"10.1016\/j.neuroscience.2026.07.057_b0075","article-title":"Characterizing the role of glycogen synthase kinase-3\u03b1\/\u03b2 in macrophage polarization and the regulation of pro-atherogenic pathways in cultured ldlr-\/-macrophages","volume":"30","author":"Patel","year":"2021","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.07.057_b0080","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s40618-019-01073-y","article-title":"p38MAPK controls fibroblast growth factor 23 (FGF23) synthesis in UMR106-osteoblast-like cells and in IDG-SW3 osteocytes","volume":"42","author":"Ewendt","year":"2019","journal-title":"J. Endocrinol. Invest."},{"issue":"13","key":"10.1016\/j.neuroscience.2026.07.057_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.03-0057fje","article-title":"Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia","volume":"17","author":"Lee","year":"2003","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.07.057_b0090","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4142\/jvs.2006.7.2.133","article-title":"Neuropharmacological effects of deltamethrin in rats","volume":"7","author":"Manna","year":"2006","journal-title":"J. Vet. Sci."},{"issue":"2\u20133","key":"10.1016\/j.neuroscience.2026.07.057_b0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0278-5846(88)90038-3","article-title":"Regional specialization of motor functions in the rat striatum: implications for the treatment of parkinsonism","volume":"12","author":"Pisa","year":"1988","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuroscience.2026.07.057_b0100","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.pbb.2007.02.010","article-title":"Effects of interleukin-1\u03b2 and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests","volume":"86","author":"Swiergiel","year":"2007","journal-title":"Pharmacol. Biochem. Behav"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.07.057_b0105","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jns.2006.06.018","article-title":"Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice","volume":"249","author":"Mohanasundari","year":"2006","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.neuroscience.2026.07.057_b0110","article-title":"Excision of whole intact mouse brain","volume":"1","author":"MacManus","year":"2023","journal-title":"MethodsX"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.07.057_b0115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.07.057_b0120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/niox.2000.0319","article-title":"A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite","volume":"5","author":"Miranda","year":"2001","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.neuroscience.2026.07.057_b0125","doi-asserted-by":"crossref","unstructured":"Buege JA, Aust SD. [30] Microsomal lipid peroxidation. InMethods in enzymology 1978 Jan 1 (Vol. 52, pp. 302-310). Academic press.","DOI":"10.1016\/S0076-6879(78)52032-6"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.07.057_b0130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.07.057_b0135","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuroscience.2026.07.057_b0140","unstructured":"Perlstein MT, editor. Immunoassay: a practical guide. Academic Press; 1987."},{"issue":"264","key":"10.1016\/j.neuroscience.2026.07.057_b0145","article-title":"Effect of weimaining on apoptosis and caspase-3 expression in a breast cancer mouse model","volume":"10","author":"Ke","year":"2021","journal-title":"J. Ethnopharmacol."},{"issue":"35","key":"10.1016\/j.neuroscience.2026.07.057_b0150","doi-asserted-by":"crossref","first-page":"9022","DOI":"10.1523\/JNEUROSCI.5216-05.2006","article-title":"Transgenic mice overexpressing glycogen synthase kinase 3\u03b2: a putative model of hyperactivity and mania","volume":"26","author":"Prickaerts","year":"2006","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.07.057_b0155","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/bmc.1130070605","article-title":"A sensitive and rapid HPLC-ECD method for the simultaneous analysis of norepinephrine, dopamine, serotonin and their primary metabolites in brain tissue","volume":"7","author":"Alburges","year":"1993","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.neuroscience.2026.07.057_b0160","article-title":"Hematoxylin and eosin staining of tissue and cell sections","author":"Fischer","year":"2008","journal-title":"CSH Protoc"},{"issue":"6676","key":"10.1016\/j.neuroscience.2026.07.057_b0165","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2026.07.057_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114917","article-title":"Betanin improves motor function and alleviates experimental Parkinsonism via downregulation of TLR4\/MyD88\/NF-\u03baB pathway: molecular docking and biological investigations","volume":"164","author":"ElSayed","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.07.057_b0175","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.3892\/mmr.2017.6252","article-title":"Wogonin protects human retinal pigment epithelium cells from LPS-induced barrier dysfunction and inflammatory responses by regulating the TLR4\/NF-\u03baB signaling pathway","volume":"15","author":"Chen","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.07.057_b0180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1527-3458.2005.tb00266.x","article-title":"Therapeutic potential of wogonin: a naturally occurring flavonoid","volume":"11","author":"Tai","year":"2005","journal-title":"CNS Drug Rev."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.07.057_b0185","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood-2007-06-096198","article-title":"Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLC1-and Ca2-dependent apoptosis","volume":"111","author":"Krammer","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.07.057_b0190","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3545169","article-title":"Protective effects of wogonin against Alzheimer\u2019s disease by inhibition of amyloidogenic pathway","volume":"2017","author":"Huang","year":"2017","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.07.057_b0195","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/toxsci\/kfr115","article-title":"Nigrostriatal proteomics of cypermethrin-induced dopaminergic neurodegeneration: microglial activation-dependent and-independent regulations","volume":"122","author":"Singh","year":"2011","journal-title":"Toxicol. Sci."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.07.057_b0200","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/WNF.0000000000000052","article-title":"Dopamine agonist modifies cortical activity in Parkinson disease: a functional neuroimaging study","volume":"37","author":"Lucetti","year":"2014","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neuroscience.2026.07.057_b0205","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0891-5849(99)00075-1","article-title":"Peripheral markers of oxidative stress in Parkinson\u2019s disease. The role of L-DOPA","volume":"27","author":"Martignoni","year":"1999","journal-title":"Free Radic. Biol. Med."},{"issue":"11","key":"10.1016\/j.neuroscience.2026.07.057_b0210","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/mnfr.200700329","article-title":"Wogonin, a bioactive flavonoid in herbal tea, inhibits inflammatory cyclooxygenase\u20102 gene expression in human lung epithelial cancer cells","volume":"52","author":"Chen","year":"2008","journal-title":"Mol. Nutr. Food Res."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.07.057_b0215","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12974-024-03277-3","article-title":"Interleukin-6 deficiency reduces neuroinflammation by inhibiting the STAT3-cGAS-STING pathway in Alzheimer\u2019s disease mice","volume":"21","author":"Liu","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"27","key":"10.1016\/j.neuroscience.2026.07.057_b0220","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.2174\/0929867329666220216113517","article-title":"Glycogen synthase kinase 3\u03b2 involvement in neuroinflammation and neurodegenerative diseases","volume":"29","author":"Gianferrara","year":"2022","journal-title":"Curr. Med. Chem."},{"issue":"37","key":"10.1016\/j.neuroscience.2026.07.057_b0225","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.2174\/1381612828666221003112300","article-title":"Microbiota-brain-gut-axis relevance to Parkinson\u2019s disease: potential therapeutic effects of probiotics","volume":"28","author":"Raj","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuroscience.2026.07.057_b0230","first-page":"S167","article-title":"Dopamine agonists and neuroprotection in Parkinson's disease","volume":"44","author":"Olanow","year":"1998","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.07.057_b0235","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s11033-024-09520-7","article-title":"Interplay between \u03b1-synuclein and parkin genes: insights of Parkinson\u2019s disease","volume":"51","author":"Sharma","year":"2024","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.07.057_b0240","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4062\/biomolther.2015.152","article-title":"Wogonin attenuates hippocampal neuronal loss and cognitive dysfunction in trimethyltin-intoxicated rats","volume":"24","author":"Lee","year":"2016","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.neuroscience.2026.07.057_b0245","article-title":"Interventions of cognitive impairment in older adults: a comprehensive review","volume":"19","author":"Chib","year":"2025","journal-title":"Aging and Health Res."},{"key":"10.1016\/j.neuroscience.2026.07.057_b0250","article-title":"NF-\u03baB and Nrf2 signaling pathways contribute to wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis","volume":"5","author":"Yao","year":"2014","journal-title":"CellDeath & Disease"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226005014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226005014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:44:49Z","timestamp":1793051089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226005014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":49,"alternative-id":["S0306452226005014"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.07.057","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological potential of wogonin in rotenone induced mice model of Parkinson\u2019s disease via targeting GSK-3\u03b2","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.07.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}